Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gottesman

Showing results (591-600 of 602) with videos related to

Pageof 61
Sort By:
Scientific Reports|December 18, 2021
Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporterRobert W Robey, Andrea N Robinson, Fatima Ali-Rahmani, et al.
Neurology|July 21, 2010
Rapid disease course in African Americans with multiple sclerosisI Kister, E Chamot, J H Bacon, et al.
Cancer Research Communications|August 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient SamplesYasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, et al.
Cancer Research|March 8, 2012
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumorsSven Rottenberg, Marieke A Vollebergh, Bas de Hoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patientsK H Cowan, J A Moscow, H Huang, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Iscience|April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Pageof 61

Showing results (591-600 of 602) with videos related to

Sort By:
Pageof 61
Scientific Reports|December 18, 2021
Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporterRobert W Robey, Andrea N Robinson, Fatima Ali-Rahmani, et al.
Neurology|July 21, 2010
Rapid disease course in African Americans with multiple sclerosisI Kister, E Chamot, J H Bacon, et al.
Cancer Research Communications|August 20, 2024
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma Cell Lines, PDX, and Patient SamplesYasuhiro Arakawa, Fathi Elloumi, Sudhir Varma, et al.
Cancer Research|March 8, 2012
Impact of intertumoral heterogeneity on predicting chemotherapy response of BRCA1-deficient mammary tumorsSven Rottenberg, Marieke A Vollebergh, Bas de Hoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patientsK H Cowan, J A Moscow, H Huang, et al.
Biorxiv : the Preprint Server for Biology|October 3, 2023
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Neuro-Oncology Advances|September 14, 2023
Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiencyOlga Kim, Madison Butler, Zach Sergi, et al.
Iscience|April 17, 2025
Exploiting the therapeutic vulnerability of IDH-mutant gliomas with zotiraciclibYing Pang, Qi Li, Zach Sergi, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Identification of DLK1, a Notch ligand, as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Nature Communications|July 2, 2025
Identification of the Notch ligand DLK1 as an immunotherapeutic target and regulator of tumor cell plasticity and chemoresistance in adrenocortical carcinomaNai-Yun Sun, Suresh Kumar, Yoo Sun Kim, et al.
Pageof 61